A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: British Journal of Cancer, 109, 2, S. 395-400
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2013
- Ereignis
-
Veröffentlichung
- (wo)
-
Edinburgh
- (wer)
-
Springer Science and Business Media LLC
- (wann)
-
2013
- Urheber
-
Absenger, G.
Szkandera, J.
Pichler, Martin
Stotz, M.
Arminger, F.
Weissmueller, M.
Schaberl-Moser, R.
Samonigg, H.
Stojakovic, T.
Gerger, A.
- DOI
-
10.1038/bjc.2013.346
- URN
-
urn:nbn:de:bvb:384-opus4-1044175
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:48 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Absenger, G.
- Szkandera, J.
- Pichler, Martin
- Stotz, M.
- Arminger, F.
- Weissmueller, M.
- Schaberl-Moser, R.
- Samonigg, H.
- Stojakovic, T.
- Gerger, A.
- Universität Augsburg
- Springer Science and Business Media LLC
Entstanden
- 2013
Ähnliche Objekte (12)
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients
The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients
Best of ASCO 2022: bladder cancer
External validation of the derived neutrophil-tolymphocyte ratio as a prognostic factor in breast cancer patients [Poster]
Emerging role of non-coding RNAs in regulation of t-lymphocyte function
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients
The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients
Best of ASCO 2022: bladder cancer
External validation of the derived neutrophil-tolymphocyte ratio as a prognostic factor in breast cancer patients [Poster]
Emerging role of non-coding RNAs in regulation of t-lymphocyte function
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer
Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma
So finden Sie den passenden Coach : der Wegweiser zum Erfolg - Antworten, die das Internet nicht gibt
Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma
The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients
Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients
The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer
External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients
Best of ASCO 2022: bladder cancer
External validation of the derived neutrophil-tolymphocyte ratio as a prognostic factor in breast cancer patients [Poster]
Emerging role of non-coding RNAs in regulation of t-lymphocyte function
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer